Clinical Trial

The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsal Myofascial Pain Syndrome.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 3, 2025 (before its estimated October 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
Back pain is commonly seen in the working-age population, with the peak occurrence around the age of 40. Its frequency does not increase with age and is not associated with age-related degenerative changes in the spine. Especially when the underlying cause is conditions such as myofascial pain syndrome (MPS), where regional muscle sensitivity in the rhomboid and trapezius areas is prominent, dry needling treatment has become increasingly popular and the subject of numerous studies in recent years. In the diagnosis of MPS, two valuable findings include the detection of a taut band upon palpation and the presence of trigger points in muscle fibers with mild finger pressure. The study we are planning involves a double-blind efficacy trial where real and sham dry needling procedures will be performed under ultrasound guidance, ensuring that both the patient and the evaluator are blinded. This study design has the potential to make a significant contribution to the literature in this field.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-24; most recent amendment 2025-08-26.
Status change: Not Yet Recruiting → Recruiting 2025-03-06
Trial Details
NCT Number NCT06338514
Lead Sponsor Kutahya Health Sciences University
Conditions Myofascial Trigger Point Pain
Enrollment 50 participants
Start Date 2024-04-25
Primary Completion 2025-10-10 (estimated)
Study Completion 2025-11-10 (estimated)
Updated on ClinicalTrials.gov 2025-09-03